Cargando...
Immune Checkpoint Inhibitors to Treat Malignant Lymphomas
Genetic and/or epigenetic changes provide antigen-derived diversity in neoplastic cells. Beside, these cells do not initiate immune response of host organisms. A variety of factors are responsible for the resistant to treatment, including individual variations in patients and somatic cell genetic di...
Gardado en:
| Publicado en: | J Immunol Res |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Hindawi
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5925139/ https://ncbi.nlm.nih.gov/pubmed/29850620 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/1982423 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|